[1]
M. Antonini, “EVALUATION OF BONE MINERAL DENSITY LOSS IN PATIENTS WITH BREAST CANCER USING AROMATASE INHIBITORS AS ADJUVANT ENDOCRINE THERAPY: 5-YEAR FOLLOW-UP”, MAST, vol. 31, p. 32, Oct. 2021.